Navigation Links
Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc.
Date:4/21/2009

NEW YORK, April 21 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. The full 56-page report can be found at www.crystalra.com.

ACT Biotech, Inc. ("ACT Biotech" or "the Company") is a closely held pharmaceutical company focused exclusively on the development and commercialization of novel cancer therapeutics. Following a technology spinout from Bayer HealthCare LLC, ACT Biotech was founded with worldwide rights to a portfolio of in-licensed compounds that now compose four oncology programs. Each program demonstrates activity against a different set of molecular targets--including several kinases that are associated with cancer cell communication and growth--in order to inhibit various signaling pathways that are important in tumor development.

The Company's lead candidate, Telatinib, is a potent and highly selective oral tyrosine kinase inhibitor compound that targets pathways associated with the formation of tumor-related blood vessels (angiogenesis). While ACT Biotech has selected gastric (stomach) cancer as Telatinib's lead clinical target, the agent has also demonstrated solid potential as a drug candidate to treat colorectal, liver, and kidney cancers. In addition, based on its ability to readily combine at full dose with various standard-of-care chemotherapy regimens, Telatinib may have expansion opportunity to treat other major cancers, such as lung, breast, and prostate cancers. Gastric cancer is the second leading cause of cancer-related death worldwide with approximately 800,000 fatalities in 2007. It is also the fourth most common cancer, with over one million new cases diagnosed in 2007. The Company aims to initially develop Telatinib in two indications, gastric and colorectal cancer, with patient enrollment for a Phase II trial set to begin during the
'/>"/>

SOURCE Crystal Research Associates, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Physicists discover important step for making light crystals
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
3. New imaging technique reveals the atomic structure of nanocrystals
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
5. Avantium Launches the Crystalline, a New Parallel System for Crystallization Research
6. ScinoPharm Granted US Patent for Novel Crystal Forms
7. Vermont Surgeon Implants First Accommodating Crystalens in Russia
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on The Medical House PLC
9. SAFC Hitech(TM) Expands Electronic Materials Portfolio With the Introduction of Scintillation Crystal Growth Halides
10. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... recognition of World Hemophilia Day, Biogen  (NASDAQ: BIIB ... than 15 prominent landmarks red throughout the United ... Bridge and Prudential Tower, Chicago,s Wrigley ... Denver,s Coors Field . The ... coincide with hemophilia community events in a dozen locations across ...
(Date:4/16/2015)... AZ (PRWEB) April 16, 2015 A ... makes it easier for research institutions to learn how ... clinical data. , The timing is ideal since Apple ... Tuesday. Research Kit is an open-source framework for developing ... It provides a way for researchers to collect secure ...
(Date:4/16/2015)... , Switzerland , April ... (Debiopharm), part of Debiopharm Group ™ , a ... that target unmet medical needs as well ... data on the investigational compounds Debio 1143 (SMAC ... be presented at the 2015 Annual meeting ...
(Date:4/16/2015)... Houston, Tex. (PRWEB) April 16, 2015 ... cold chain management systems for highly regulated industries, ... has been name a monthly columnist for Cold ... Network ( http://www.coldchainiq.com ). His column titled, Global ... cold chain information for today’s life sciences, pharmaceutical ...
Breaking Biology Technology:Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3
... Inc. (Nasdaq: SGMO ) today announced that the ... Wednesday, April 30,2008, after the market closes. The press ... p.m. PT, which will be open to the public ... will review,the financial results and discuss other business matters., ...
... Schering-Plough,Corporation (NYSE: SGP ) today announced two ... franchises in Europe. These agreements are,in connection with ... part,of its October 2007 clearance of Schering-Plough,s acquisition ... N.V., In two separate agreements, Pfizer and ...
... the First Eight Months Since its Introduction in the ... VYVANSE has Achieved Over One Million Prescriptions,In ... Significantly Improve the Symptoms of ADHD (Inattention, Hyperactivity ... /PRNewswire-FirstCall/,-- Shire plc (LSE: SHP) (NASDAQ: SHPGY,), the global ...
Cached Biology Technology:Sangamo BioSciences Announces First Quarter Conference Call and Webcast 2Sangamo BioSciences Announces First Quarter Conference Call and Webcast 3Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe 2FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 2FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 3FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 4FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 5FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 6FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 7FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults 8
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced ... Strategic Business Report" report to their offering. This ... US$ Thousands by the following Segments: Face Biometrics, and Voice Biometrics. ... Canada , Japan , Europe ... & Africa , and ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... Mass-- Cancer cells metastasize in several stages -- first ... via the circulatory system. Some circulating cells work their ... secondary tumor. While the initial process by which ... is well characterized, how cells escape blood vessels to ...
... molecular biology, the ribosome represents the machinery necessary to ... process, information encoded in the genome,s DNA is first ... to the ribosome where protein-assembly instructions are put in ... But in recent years, it has been demonstrated that ...
... Institutes of Health is making available approximately $3.7 ... graduate students and postdoctoral scholars to prepare them ... could take them outside of conventional academic research. ... Experience in Scientific Training (BEST) awards are supported ...
Cached Biology News:Microfluidic platform gives a clear look at a crucial step in cancer metastasis 2Microfluidic platform gives a clear look at a crucial step in cancer metastasis 3Global analysis reveals new insights into the ribosome -- with important implications for disease 2Global analysis reveals new insights into the ribosome -- with important implications for disease 3Global analysis reveals new insights into the ribosome -- with important implications for disease 4NIH announces awards to strengthen the biomedical research workforce 2NIH announces awards to strengthen the biomedical research workforce 3
... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
... Sensitive Bio (for heat-labile and very volatile ... to specific applications of molecular biology and ... heat-labile samples. The RC systems can be ... and a wide selection of rotors (eliminating ...
... personal desktop unit ideal for use in laboratories ... Rotation speed set at 12 rpm , ... , Bottle capacity of four 35 x 150mm ... ,plastic bottles , Consistent, repeatable results achieved ...
... SC250 Express is the latest edition to ... Express has an extra large diameter exhaust ... digital display panel allows precise setting and ... chamber for handling large quantities and samples ...
Biology Products: